Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

ORCID: 0000-0003-1760-5244

Publication year:
All
51 - 60 out of 139Page size: 10
Sort by: Title
  1. Published

    Ganglioside composition correlates with the malignant phenotype of cholangiocarcinoma cells and modulates cell adhesion

    Mannini, A., Raggi, C., Correnti, M., Rovida, E., Andersen, Jesper Bøje, Coulouarn, C. & Marra, F., 2019, In: Digestive and Liver Disease. 51, p. e7

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  2. Published

    Ganglioside patterns in the human cholangiocarcinoma stem cell subset A

    Mannini, A., Raggi, C., Correnti, M., Rovida, E., Piombanti, B., Pastore, M., Aureli, M., Carsana, E. V., Andersen, Jesper Bøje, Coulouarn, C. & Marra, F., 1 Feb 2020, In: Digestive and Liver Disease. 52, p. e11 1 p.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  3. Published

    Genetic Optimization of Liver Cancer Therapy: A Patient-derived Primary Cancer Cell-based Model

    Munoz-Garrido, P. & Andersen, Jesper Bøje, 23 Nov 2016, In: Gastroenterology. 152, 1

    Research output: Contribution to journal › Editorial › Research › peer-review

  4. Published

    Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features

    Haefliger, S., Hench, J., O'Rourke, Colm, Meyer-Schaller, N., Uzun, S., Saldarriaga, J., Weber, A., Mazzucchelli, L., Jermann, P., Frank, S., Andersen, Jesper Bøje, Terracciano, L., Sempoux, C. & Matter, M. S., 2023, In: Histopathology. 82, 5, p. 722–730 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Genetic profiling of intrahepatic cholangiocarcinoma

    Andersen, Jesper Bøje & Thorgeirsson, S. S., May 2012, In: Current Opinion in Gastroenterology. 28, 3, p. 266-72 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    Genomic Perturbations Reveal Distinct Regulatory Networks in Intrahepatic Cholangiocarcinoma

    Nepal, C., O'Rourke, Colm, Oliveira, D. V., Taranta, A., Shema, S., Gautam, P., Calderaro, J., Barbour, A., Raggi, C., Wennerberg, Krister, Wang, X. W., Lautem, A., Roberts, L. R. & Andersen, Jesper Bøje, Sep 2018, In: Hepatology. 68, 3, p. 949-963 15 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors

    Andersen, Jesper Bøje, Spee, B., Blechacz, B. R., Avital, I., Komuta, M., Barbour, A., Conner, E. A., Gillen, M. C., Roskams, T., Roberts, L. R., Factor, V. M. & Thorgeirsson, S. S., Apr 2012, In: Gastroenterology. 142, 4, p. 1021-1031.e15

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Genomic decoding of intrahepatic cholangiocarcinoma reveals therapeutic opportunities

    Andersen, Jesper Bøje & Thorgeirsson, S. S., Apr 2013, In: Gastroenterology. 144, 4, p. 687-90 4 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  9. Published

    Heterogeneity Among Liver Cancer—A Hurdle to Optimizing Therapy

    Birkbak, N. J. & Andersen, Jesper Bøje, Apr 2016, In: Gastroenterology. 150, 4, p. 818–821 4 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

  10. Published

    High mobility group A1 enhances tumorigenicity of human cholangiocarcinoma and confers resistance to therapy

    Quintavalle, C., Burmeister, K., Piscuoglio, S., Quagliata, L., Karamitopoulou, E., Sepe, R., Fusco, A., Terracciano, L. M., Andersen, Jesper Bøje, Pallante, P. & Matter, M. S., Sep 2017, In: Molecular Carcinogenesis. 56, 9, p. 2146–2157

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 12 3 4 5 6 7 8 9 ...14 Next

ID: 93714085